EWT Performance — iShares MSCI Taiwan ETF
Data updated: 2026-07-27
EWT returned +60.96% year to date and +103.27% over one year to May 2026. Annualised returns are +38.98% over 3 years and +19.43% over 5 years. The fund beat its Taiwan Technology Equity category average: $100 invested three years ago grew to $268, against $160 for the category, and to $203 over one year, against $131. Volatility over the past three years was 23.16% a year. In the 12 months to May 2026 the fund took in a net $362.6M, and assets reached $10.75B.
EWT Growth of $100
What $100 invested in iShares MSCI Taiwan ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Taiwan Technology Equity category average over the same months.
| Period | EWT | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $203 | $131 |
| 3 years (Jun 2023 – May 2026) | $268 | $160 |
| 5 years (Jun 2021 – May 2026) | $243 | $109 |
| Since data start (Sep 2019 – May 2026) | $452 | $176 |
EWT Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +60.96% |
| 1 year | +103.27% |
| 3 years (annualised) | +38.98% |
| 5 years (annualised) | +19.43% |
EWT Annual Returns
Calendar-year total returns of iShares MSCI Taiwan ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +60.96% |
| 2025 | +27.80% |
| 2024 | +16.78% |
| 2023 | +29.14% |
| 2022 | −28.76% |
| 2021 | +28.37% |
| 2020 | +32.38% |
| 2019 (Sep–Dec) | +20.35% |
EWT Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +7.4% | +11.3% | −7.3% | +26.0% | +15.2% | — | — | — | — | — | — | — |
| 2025 | −0.3% | −1.2% | −7.0% | +0.2% | +10.3% | +8.5% | +2.7% | +0.1% | +7.9% | +4.8% | −3.1% | +3.3% |
| 2024 | −3.0% | +4.3% | +4.3% | −2.8% | +6.8% | +7.5% | −2.4% | +1.9% | +0.2% | −0.1% | −1.5% | +1.0% |
| 2023 | +11.5% | −1.8% | +3.5% | −3.1% | +5.3% | +1.8% | +2.1% | −5.0% | −2.5% | −2.3% | +12.3% | +5.8% |
| 2022 | −1.8% | −2.0% | −3.8% | −9.0% | +2.8% | −12.2% | +1.9% | −2.2% | −14.0% | −3.9% | +21.0% | −6.0% |
| 2021 | +3.7% | +5.5% | +1.8% | +9.4% | −4.1% | +3.1% | −1.4% | +2.4% | −3.8% | +1.5% | +2.1% | +5.8% |
| 2020 | −4.9% | −2.0% | −13.8% | +14.5% | −1.9% | +8.7% | +11.7% | −2.0% | +1.2% | +1.4% | +9.4% | +9.7% |
| 2019 | — | — | — | — | — | — | — | — | +3.7% | +7.4% | +1.3% | +6.6% |
EWT Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 23.16%
- 3-year Sharpe ratio: 1.49 (vs 4.5% risk-free rate)
- Best month: +26.01% (Apr 2026)
- Worst month: −7.26% (Mar 2026)
EWT Fund Flows
Monthly money in and out of iShares MSCI Taiwan ETF, from SEC Form N-PORT.
- 12-month net flow: $362.6M
- 12-month gross sales (incl. reinvestments): $1.7B
- Sales ÷ redemptions: 1.27×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $239.9M | $0 | $239.9M |
| Apr 2026 | $226.1M | $137.2M | $88.9M |
| Mar 2026 | $0 | $976.9M | −$976.9M |
| Feb 2026 | $245.5M | $0 | $245.5M |
| Jan 2026 | $217.3M | $0 | $217.3M |
| Dec 2025 | $60.7M | $90 | $60.7M |
| Nov 2025 | $233.3M | $2 | $233.3M |
| Oct 2025 | $59.1M | $0 | $59.1M |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $89.9M | −$89.9M |
| Jul 2025 | $0 | $82.4M | −$82.4M |
| Jun 2025 | $436.7M | $69.5M | $367.2M |
EWT Assets Under Management
Net assets of iShares MSCI Taiwan ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $10.75B |
| 2026-02-28 | $8.79B |
| 2025-11-30 | $6.98B |
| 2025-08-31 | $6.10B |
| 2025-05-31 | $5.28B |
| 2025-02-28 | $5.19B |
| 2024-11-30 | $5.45B |
| 2024-08-31 | $5.23B |
| 2024-05-31 | $4.91B |
| 2024-02-29 | $3.80B |
| 2023-11-30 | $3.62B |
| 2023-08-31 | $3.28B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.